Search results
Found 11 matches for
Professor Tonia Vincent, of the Kennedy Institute of Rheumatology, discusses osteoarthritis of the hand on Radio 4's Woman's Hour.
WHITE-5
Botnar Hip
FAIT
Botnar Hip
FAIT is a multicentre randomised controlled clinical trial comparing surgical and non-surgical approaches to treating femoroacetabular impingement (hip impingement).
Glyn-Jones Group | Hip Research Group
Botnar Hip
Our research focuses on hip osteoarthritis, from identifying its causes to developing new surgery techniques for the condition.
Find out more
-
Tonia Vincent
Professor of Musculoskeletal Biology
BBC Radio 4 Woman's Hour
(at 37')
Find out more about
Similar stories
Study finds marked differences in the use of ankle replacements across six countries
18 June 2021
A new study published in Foot and Ankle International reviews the use of ankle replacements across 6 countries to predict why there is a variance in their use, and to determine how far current demands are being met.
NDORMS wins government funding to develop AI for bone health
17 June 2021
A state-of-the-art method that uses artificial intelligence to check bone health and reduce fracture risk has been successful in the latest round of the Artificial Intelligence in Health and Care Award.
COVID-19 vaccine safety monitoring should account for age, gender, and database differences
14 June 2021
The largest, most extensive global network study on background rates for adverse events of special interest identifies important age, sex and database differences that should inform future safety surveillance efforts.
Professor Keith Willett recognised in Queen’s Birthday Honours
14 June 2021
Professor of Orthopaedic Trauma Surgery at NDORMS, Keith Willett becomes a Knight Bachelor for services to the NHS.
Professor Dani Prieto-Alhambra elected to ISPE Board of Directors
11 June 2021
Dani Prieto-Alhambra, Professor of Pharmaco- and Device Epidemiology at NDORMS, has been elected as the Academic representative for Europe and Africa on the International Society of Pharmaco-Epidemiology Board of Directors.
New research from the Kennedy Institute of Rheumatology identifies a role for CD200 in limiting atherosclerosis
10 June 2021
A new study published in Circulation Research shows that CD200, an inhibitory immune checkpoint, reduces the development of atherosclerosis.